Cargando…
Identification of differentially expressed genes using an annealing control primer system in stage III serous ovarian carcinoma
BACKGROUND: Most patients with ovarian cancer are diagnosed with advanced stage disease (i.e., stage III-IV), which is associated with a poor prognosis. Differentially expressed genes (DEGs) in stage III serous ovarian carcinoma compared to normal tissue were screened by a new differential display m...
Autores principales: | Kim, Yun-Sook, Hwan Do, Jin, Bae, Sumi, Bae, Dong-Han, Shick Ahn , Woong |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2974737/ https://www.ncbi.nlm.nih.gov/pubmed/20969748 http://dx.doi.org/10.1186/1471-2407-10-576 |
Ejemplares similares
-
Development of Multiplexed Bead-Based Immunoassays for the Detection of Early Stage Ovarian Cancer Using a Combination of Serum Biomarkers
por: Kim, Yong-Wan, et al.
Publicado: (2012) -
Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas
por: Österberg, Lovisa, et al.
Publicado: (2009) -
Thrombocytosis as a prognostic marker in stage III and IV serous ovarian cancer
por: Digklia, Antonia, et al.
Publicado: (2014) -
Comparison of stage III mucinous and serous ovarian cancer: a case-control study
por: Firat Cuylan, Zeliha, et al.
Publicado: (2018) -
Outcomes of fertility-sparing surgery for stage II and III serous borderline ovarian tumors
por: Lu, Ziyang, et al.
Publicado: (2019)